Protein Engineering Market worth US$ 2.9 Billion 2024 with a CAGR of 15.80%
The
report "Protein
Engineering Market, By Product Type (Modified Enzymes, Insulin, Monoclonal
Antibodies, Coagulation Factors, Vaccines, Growth Factors, and Other Product
Types), By Technology (Irrational Protein Design, and Rational Protein Design),
By End User (Pharmaceutical and Biotechnology Companies, Academic Institutions,
and Contract Research Organizations), and By Region (North America,
Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends,
Analysis and Forecast till 2030.”
·
In June 2019, Thermo Fisher Scientific Launches
powerful Invitrogen iBright 1500 imaging system for western blot and gel
imaging.
·
In July 2019, Amgen and the University of Washington's Institute for
Protein Design (IPD), which is
revolutionizing its field of science by creating custom-designed proteins from
scratch to improve human health, today announced a broad collaboration that
will cover multiple projects with a goal of testing new technologies and
creating protein-building approaches that can be broadly applied to the search
for new medicines.
Analyst View:
The propelling factors for the growth of the global protein engineering market include the increasing prevalence of protein deficient diseases, increase in adoption of protein drugs over non-protein drugs. In addition, increased demand for alternatives to chemical processes, and rising government funding for protein engineering will further boost the growth of target market. Factors such as the increasing investments in synthetic biology and the growing focus on protein-based drug development by pharmaceutical and biotechnology companies are expected to drive the growth of global protein engineering market. There is a rising number of government initiatives, such as funding R&D for protein engineering and awareness programs, which have influenced the healthcare industry. The government is thus proactively investing in many of the research studies. For instance, Protein Technologies Ltd (PTL) has received funding from the UK government’s Technology Strategy Board (now Innovate UK) for its innovative research in protein engineering. Hence the increasing number of government initiatives for the efficient protein engineering research helps in driving the overall growth of the market.
The
global Protein Engineering market accounted for US$ 2.9
billion by 2024 and is projected to register a moderate CAGR of 15.80% over the
forecast period. The market report has been segmented on the basis of product
type, technology, end user, and region.
·
By product type, monoclonal antibody accounted
for a dominant share of the protein type segment and are anticipated to grow at
a lucrative rate during the forecast period. Growing R&D expenditure in
development of therapeutically advanced mAbs is presumed to be one of the
significant factors responsible for increased adoption of these tools.
·
By technology, rational design dominated the
technology segment with a share of over 39.0%. The dominant share can be
attributed to extensive usage of this technology in antibody and enzyme
engineering.
·
By end user, Pharmaceutical & biotechnology
companies held a dominant share in the end-use segment in 2016. The substantial
share can be attributed to the increasing adoption of in silico models to
develop new protein-based drugs in the following applications: cancer,
diabetes, and central nervous system diseases.
·
By region, North America captured a dominant
share of the market. Consistent number of collaborations encouraged by key
market players for increasing their R&D capabilities are presumed to be
responsible for the greater share captured by this region.
Before purchasing
this report, request a sample or make an inquiry by clicking the following
link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4118
Competitive
Landscape:
The prominent
player operating in the global Protein Engineering market includes Thermo
Fisher Scientific, Danaher Corporation, Agilent Technologies, Bio-Rad
Laboratories, Amgen Inc., Bruker Corporation, General Electric, PerkinElmer,
Inc., Genscripts USA, Inc., and Sigma-Aldrich Corporation.
The market
provides detailed information regarding industrial base, productivity,
strengths, manufacturers, and recent trends which will help companies enlarge
the businesses and promote financial growth. Furthermore, the report exhibits
dynamic factors including segments, sub-segments, regional marketplaces,
competition, dominant key players, and market forecasts. In addition, the
market includes recent collaborations, mergers, acquisitions, and partnerships
along with regulatory framework across different regions impacting the market
trajectory. Recent technological advances and innovations influencing the
global market are included into the report.
Prophecy
Market Insights is specialized market research, analytics, marketing/business
strategy, and solutions that offers strategic and tactical support to clients
for making well-informed business decisions and to identify and achieve
high-value opportunities in the target business area. We also help our clients
to address business challenges and provide the best possible solutions to
overcome them and transform their business.
Contact Us:
Sales
Prophecy Market Insights
Email- sales@prophecymarketinsights.com
Website- www.prophecymarketinsights.com

Comments
Post a Comment